NexgenRx Announces Q2 2022 Financial Results with Continued Revenue Growth, Positive EBITDA and Increased Free Cash Flow
19.08.2022 - TORONTO, ON / ACCESSWIRE / August 18, 2022 / NEXGENRX INC. ('NexgenRx' or the 'Company') is pleased to announce its interim financial results for the second quarter ended June 30, 2022, highlighted by continued revenue growth, positive EBIDTA and ... Seite 1
Source: wallstreet-online.de